. . . . . . . . . "454 Life Sciences"@en . "2000"^^ . . . . "13269"^^ . . . . "Acquired byRochein 2007 and shut down by Roche in 2013 (production ceased mid-2016)"@en . . . . . . . . "454 Life Sciences was a biotechnology company based in Branford, Connecticut that specialized in high-throughput DNA sequencing. It was acquired by Roche in 2007 and shut down by Roche in 2013 when its technology became noncompetitive, although production continued until mid-2016."@en . . "La 454 Life Sciences \u00E8 una compagnia statunitense con sede a Branford, nel Connecticut specializzata nel sequenziamento ad elevato parallelismo utilizzando una nuova tecnologia di basata su un approccio di sequencing by synthesis (sequenziamento durante la sintesi).La compagnia, fondata nel 2000, ha avuto un'enorme crescita in seguito al rilascio, nel 2005, del primo macchinario di sequenziamento di nuova generazione (G20) al mondo e, in seguito, alla sua acquisizione da parte della Roche."@it . "La 454 Life Sciences \u00E8 una compagnia statunitense con sede a Branford, nel Connecticut specializzata nel sequenziamento ad elevato parallelismo utilizzando una nuova tecnologia di basata su un approccio di sequencing by synthesis (sequenziamento durante la sintesi).La compagnia, fondata nel 2000, ha avuto un'enorme crescita in seguito al rilascio, nel 2005, del primo macchinario di sequenziamento di nuova generazione (G20) al mondo e, in seguito, alla sua acquisizione da parte della Roche."@it . . "1123467455"^^ . "454 Life Sciences was a biotechnology company based in Branford, Connecticut that specialized in high-throughput DNA sequencing. It was acquired by Roche in 2007 and shut down by Roche in 2013 when its technology became noncompetitive, although production continued until mid-2016."@en . . . . . "Acquired by Roche in 2007 and shut down by Roche in 2013"@en . "\u0639\u0644\u0648\u0645 \u062D\u064A\u0627\u0629 454 \u0647\u064A \u0634\u0631\u0643\u0629 \u0644\u0644\u062A\u0643\u0646\u0648\u0644\u0648\u062C\u064A\u0627 \u0627\u0644\u062D\u064A\u0648\u064A\u0629 \u0645\u0642\u0631\u0647\u0627 \u0641\u064A \u0628\u0631\u0627\u0646\u0641\u0648\u0631\u062F\u060C \u0643\u0648\u0646\u064A\u062A\u064A\u0643\u062A \u0645\u062A\u062E\u0635\u0635\u0629 \u0641\u064A \u062A\u0633\u0644\u0633\u0644 \u0627\u0644\u062D\u0645\u0636 \u0627\u0644\u0646\u0648\u0648\u064A \u0639\u0627\u0644\u064A \u0627\u0644\u0625\u0646\u062A\u0627\u062C\u064A\u0629. \u0627\u0633\u062A\u062D\u0648\u0630\u062A \u0639\u0644\u064A\u0647\u0627 \u0634\u0631\u0643\u0629 \u0647\u0648\u0641\u0645\u0627\u0646-\u0644\u0627\u0631\u0648\u0634 \u0641\u064A \u0639\u0627\u0645 2007 \u0648\u0623\u063A\u0644\u0642\u062A\u0647\u0627 \u0641\u064A \u0639\u0627\u0645 2013 \u0639\u0646\u062F\u0645\u0627 \u0623\u0635\u0628\u062D\u062A \u062A\u0642\u0646\u064A\u062A\u0647\u0627 \u063A\u064A\u0631 \u0642\u0627\u062F\u0631\u0629 \u0639\u0644\u0649 \u0627\u0644\u0645\u0646\u0627\u0641\u0633\u0629\u060C \u0639\u0644\u0649 \u0627\u0644\u0631\u063A\u0645 \u0645\u0646 \u0627\u0633\u062A\u0645\u0631\u0627\u0631 \u0627\u0644\u0625\u0646\u062A\u0627\u062C \u062D\u062A\u0649 \u0645\u0646\u062A\u0635\u0641 \u0639\u0627\u0645 2016."@ar . . "454\u751F\u7269\u79D1\u5B66"@zh . . . "454 Life Sciences"@es . "454 Life Sciences"@fr . . . "454"^^ . . "454 Life Sciences es una empresa de biotecnolog\u00EDa con sede en Branford, Connecticut. Es una subsidiaria de Hoffmann-La Roche y se especializa en secuenciaci\u00F3n de ADN.Fue adquirida por Roche en 2007 y cerrada por Roche en 2013 cuando su tecnolog\u00EDa dej\u00F3 de ser competitiva, aunque la producci\u00F3n continu\u00F3 hasta mediados de 2016.\u200B"@es . . . "454 Life Sciences est une soci\u00E9t\u00E9 bas\u00E9e \u00E0 Branford dans le Connecticut aux \u00C9tats-Unis, sp\u00E9cialis\u00E9e dans la fabrication de s\u00E9quenceur de g\u00E8nes \u00E0 haut d\u00E9bit. La soci\u00E9t\u00E9 fut rachet\u00E9e par Roche en 2007 et est maintenant une filiale de celle-ci. C'est la soci\u00E9t\u00E9 qui s'est lanc\u00E9e dans le projet de s\u00E9quen\u00E7age du g\u00E9nome de l'homme de N\u00E9andertal, en collaboration avec le Max-Planck-Institut."@fr . . . "Sequencing of genetic samples"@en . . . "\u0639\u0644\u0648\u0645 \u062D\u064A\u0627\u0629 454 \u0647\u064A \u0634\u0631\u0643\u0629 \u0644\u0644\u062A\u0643\u0646\u0648\u0644\u0648\u062C\u064A\u0627 \u0627\u0644\u062D\u064A\u0648\u064A\u0629 \u0645\u0642\u0631\u0647\u0627 \u0641\u064A \u0628\u0631\u0627\u0646\u0641\u0648\u0631\u062F\u060C \u0643\u0648\u0646\u064A\u062A\u064A\u0643\u062A \u0645\u062A\u062E\u0635\u0635\u0629 \u0641\u064A \u062A\u0633\u0644\u0633\u0644 \u0627\u0644\u062D\u0645\u0636 \u0627\u0644\u0646\u0648\u0648\u064A \u0639\u0627\u0644\u064A \u0627\u0644\u0625\u0646\u062A\u0627\u062C\u064A\u0629. \u0627\u0633\u062A\u062D\u0648\u0630\u062A \u0639\u0644\u064A\u0647\u0627 \u0634\u0631\u0643\u0629 \u0647\u0648\u0641\u0645\u0627\u0646-\u0644\u0627\u0631\u0648\u0634 \u0641\u064A \u0639\u0627\u0645 2007 \u0648\u0623\u063A\u0644\u0642\u062A\u0647\u0627 \u0641\u064A \u0639\u0627\u0645 2013 \u0639\u0646\u062F\u0645\u0627 \u0623\u0635\u0628\u062D\u062A \u062A\u0642\u0646\u064A\u062A\u0647\u0627 \u063A\u064A\u0631 \u0642\u0627\u062F\u0631\u0629 \u0639\u0644\u0649 \u0627\u0644\u0645\u0646\u0627\u0641\u0633\u0629\u060C \u0639\u0644\u0649 \u0627\u0644\u0631\u063A\u0645 \u0645\u0646 \u0627\u0633\u062A\u0645\u0631\u0627\u0631 \u0627\u0644\u0625\u0646\u062A\u0627\u062C \u062D\u062A\u0649 \u0645\u0646\u062A\u0635\u0641 \u0639\u0627\u0645 2016."@ar . . . "Genome sequencers, reagents"@en . . . . . . . . . . . . . . . . . . "454 Life Sciences"@en . . . . "USA"@en . "6375012"^^ . . . . . . . "454\u751F\u7269\u79D1\u5B66\u662F\u4F4D\u4E8E\u7F8E\u56FD\u5EB7\u6D85\u72C4\u683C\u5DDE\u7684\u751F\u7269\u6280\u672F\u516C\u53F8\u3002\u4ED6\u4EEC\u7684\u4E3B\u8981\u4EA7\u54C1\u662F\u6280\u672F\u3002"@zh . . "2000"^^ . . . . . . . . . . "454 Life Sciences"@it . . . . "454 Life Sciences est une soci\u00E9t\u00E9 bas\u00E9e \u00E0 Branford dans le Connecticut aux \u00C9tats-Unis, sp\u00E9cialis\u00E9e dans la fabrication de s\u00E9quenceur de g\u00E8nes \u00E0 haut d\u00E9bit. La soci\u00E9t\u00E9 fut rachet\u00E9e par Roche en 2007 et est maintenant une filiale de celle-ci. C'est la soci\u00E9t\u00E9 qui s'est lanc\u00E9e dans le projet de s\u00E9quen\u00E7age du g\u00E9nome de l'homme de N\u00E9andertal, en collaboration avec le Max-Planck-Institut."@fr . . . . . . . . . "454\u751F\u7269\u79D1\u5B66\u662F\u4F4D\u4E8E\u7F8E\u56FD\u5EB7\u6D85\u72C4\u683C\u5DDE\u7684\u751F\u7269\u6280\u672F\u516C\u53F8\u3002\u4ED6\u4EEC\u7684\u4E3B\u8981\u4EA7\u54C1\u662F\u6280\u672F\u3002"@zh . . . . "454 Life Sciences es una empresa de biotecnolog\u00EDa con sede en Branford, Connecticut. Es una subsidiaria de Hoffmann-La Roche y se especializa en secuenciaci\u00F3n de ADN.Fue adquirida por Roche en 2007 y cerrada por Roche en 2013 cuando su tecnolog\u00EDa dej\u00F3 de ser competitiva, aunque la producci\u00F3n continu\u00F3 hasta mediados de 2016.\u200B"@es . . . . . "\u0639\u0644\u0648\u0645 \u062D\u064A\u0627\u0629 454"@ar . . . . . .